Stock ISOFOL ISOFOL MEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Isofol Medical AB

Equities

ISOFOL

SE0009581051

Pharmaceuticals

Market Closed - Nasdaq Stockholm
Other stock markets
 10:54:47 2024-04-19 am EDT 		5-day change 1st Jan Change
0.734 SEK -0.68% Intraday chart for Isofol Medical AB +0.69% +0.55%
Feb. 20 Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Feb. 20 Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Isofol Medical AB (publ) is a Sweden-based clinical stage pharmaceutical company. Its primary product is Modufolin, the active metabolite. Modufolin is a folate-based compound, which increases the efficiency and reduces the side effects of chemotherapy. Modufolin contains the key active substance methylenetetrahydrofolate (MTHF), which is the active metabolite in all folate-based medicines and therefore does not require metabolic activation to exert its action. The Company cooperates with pharmaceutical manufacturer Merck & Co Inc, as well as the Company has a worldwide supply and licence agreement for the use of Modufolin in cancer treatment. The Company’s main shareholders are Biofol AB and Yield Life Science AB.

Number of employees: 3

Sales per Business

SEK in Million2022Weight2023Weight Delta
Arfolitixorin
100.0 %
13 100.0 % 1 100.0 % -94.37%

Sales per region

SEK in Million2022Weight2023Weight Delta
Asia
100.0 %
13 100.0 % 1 100.0 % -94.37%

Managers

Managers TitleAgeSince
Petter Lindqvist CEO
 Chief Executive Officer - Jan. 08
Magnus Hurst DFI
 Director of Finance/CFO - Jan. 09
Roger Tell CTO
 Chief Tech/Sci/R&D Officer 59 19-01-31

Members of the board

Members of the board TitleAgeSince
Lars Erik Lind CHM
 Chairman 83 -
Sten Nilsson BRD
 Director/Board Member 76 Jan. 03
Alain Herrera BRD
 Director/Board Member 74 17-12-31
Jan-Eric Österlund CHM
 Chairman 79 23-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 161,515,440 101,415,382 ( 62.79 %) 0 62.79 %

Shareholders

NameEquities%Valuation
Handelsbanken Fonder AB
5.131 %
8,287,069 5.131 % 598 326 kr
Alfred Berg Kapitalförvaltning AB
0.001449 %
2,340 0.001449 % 169 kr

Company contact information

Isofol Medical AB

Biotech Center Arvid Wallgrens Backe 20

413 46, Gothenburg

+46 3 17 97 22 80

http://www.isofol.se
address Isofol Medical AB(ISOFOL)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
ISOFOL MEDICAL AB Stock Isofol Medical AB
+0.55% 10.93M
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.08% 9.12B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-17.63% 4.8B
YUHAN CORPORATION Stock Yuhan Corporation
+0.73% 3.8B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+16.55% 3.72B
INDIVIOR PLC Stock Indivior PLC
+27.76% 2.58B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-26.11% 2.36B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-30.09% 2.11B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+7.15% 1.86B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ISOFOL Stock
  4. Company Isofol Medical AB